Your browser doesn't support javascript.
loading
Evaluation of new thiazolide/thiadiazolide derivatives reveals nitro group-independent efficacy against in vitro development of Cryptosporidium parvum.
Gargala, Gilles; Le Goff, Laetitia; Ballet, Jean-Jacques; Favennec, Loic; Stachulski, Andrew V; Rossignol, Jean-François.
Afiliação
  • Gargala G; Parasitology Department, Rouen University Hospital and UPRES-EA 4311-IFRMP 23, University of Rouen, Rouen, France. gilles.gargala@univ-rouen.fr
Antimicrob Agents Chemother ; 54(3): 1315-8, 2010 Mar.
Article em En | MEDLINE | ID: mdl-20047919
ABSTRACT
Thirty-nine new thiazolide/thiadiazolide compounds were compared with the nitrothiazole nitazoxanide for activity against Cryptosporidium parvum development in HCT-8 cells. Twenty-seven agents exerted > or =90% inhibition. Agents with a lower 50% inhibitory concentration (IC(50)) than nitazoxanide were either NO(2) or halogen 5 substituted on the thiazole moiety. Other 5 substitutions such as methyl, C(3)H(7), C(6)H(11), H, SO(2)CH(3), and SCH(3) negatively impacted activity. Five-substituted deacetylated analogues exhibited higher IC(50)s than their acetylated counterparts. Halogeno-thiazolide/thiadiazolides may provide valuable nitro-free alternatives to nitazoxanide.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiadiazinas / Tiazóis / Cryptosporidium parvum Idioma: En Ano de publicação: 2010 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tiadiazinas / Tiazóis / Cryptosporidium parvum Idioma: En Ano de publicação: 2010 Tipo de documento: Article